Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Avir Green Hills Biotechnology AG
DescriptionOncolytic virus based on modified influenza
Molecular Target
Mechanism of ActionOncolytic virus
Therapeutic ModalityPreventive vaccine: Viral vaccine
Latest Stage of DevelopmentPreclinical
Standard IndicationMelanoma
Indication DetailsTreat melanoma
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today